Copyright
©The Author(s) 2021.
World J Cardiol. Jul 26, 2021; 13(7): 223-229
Published online Jul 26, 2021. doi: 10.4330/wjc.v13.i7.223
Published online Jul 26, 2021. doi: 10.4330/wjc.v13.i7.223
Table 2 Summary of patient adverse events for fractional flow reserve coronary guidewires
| Adverse patient events | VerrataTM (Philips), n = 58 | CometTM (Boston Scientific), n = 29 | PressureWireTM X (Abbott), n = 46 | Total, n = 133 |
| Retained guidewire tip | 27 (46.6) | 22 (75.9) | 22 (47.8) | 71 (53.4) |
| Stent dislodgement | 18 (31.0) | 0 (0) | 8 (17.4) | 26 (19.6) |
| Vessel dissection | 8 (13.0) | 4 (13.8) | 11 (23.9) | 23 (17.3) |
| Death | 2 (3.4) | 2 (6.9) | 3 (6.5) | 7 (5.3) |
| Vessel perforation | 3 (5.2) | 1 (3.5) | 2 (4.4) | 6 (4.5) |
- Citation: Khalid N, Pandey Y, Khalid U, Kamran H, Wermers JP, Chhabra L, Alam M, Jneid H, Kayani WT. Modes of failure with fractional flow reserve guidewires: Insights from the manufacturer and user facility device experience database. World J Cardiol 2021; 13(7): 223-229
- URL: https://www.wjgnet.com/1949-8462/full/v13/i7/223.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i7.223